Paraneoplastic dermatomyositis with cutaneous and myopathic disease responsive to adrenocorticotropic hormone therapy

Marisa Wolff, Christopher Mancuso, Karan Lal, Damian Dicostanzo, Charles Gropper

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Dermatomyositis is a myopathic or amyopathic autoimmune connective tissue disease that presents with classic dermatologic Andings ranging from: poikilodermatous photosensitivity (shawl sign), eyelid edema and violaceouspigmentation (heliotrope sign), lichenoid eruptions on the knuckles and elbows (Gottron's sign), periungual telangiectasias, and ragged cuticles (Samitz sign). up to 30 percent of adultonset cases of dermatomyositis may represent a paraneoplastic syndrome warranting a thorough work-up for malignancy. The authors present a case report of paraneoplastic dermatomyositis associated with triple negative, BRCA-1 positive, invasive intraductal carcinoma of the breast, whose myopathic and cuteanous symptoms were recalcitrant to high-dose corticosteroid therapy. Herein, the authors describe the Arst reported case of the use of an injectable adrenocorticotropic hormone agonist gel in a patient with myopathic paraneoplastic disease that achieved clinical resolution of both myopathic and cutaneous symptoms, but subseuqently developed signiAcant hyperpigmentation of her face suspected to be secondary to a chemotherapeutic-induced pigmentary change which was augmented by adrenocorticotropic hormone therapy.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalJournal of Clinical and Aesthetic Dermatology
Volume10
Issue number1
StatePublished - Jan 2017

Fingerprint

Dive into the research topics of 'Paraneoplastic dermatomyositis with cutaneous and myopathic disease responsive to adrenocorticotropic hormone therapy'. Together they form a unique fingerprint.

Cite this